The Effect of Bortezomib on Antibody Titers Against Common Viral and Vaccine Antigens

The primary objective of this study is to determine whether bortezomib treatment affects the antibody titers against infectious diseases that patients are routine vaccinated against as children. A secondary objective is to examine antibody titers spontaneously recover followingcompletion of treatment.

Study Number: 

I 239513

Principal Investigator: 

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724) or e-mail